By Becky Oskin
Cyanobacteria, one of Earth’s oldest life forms, offer a promising new source of petroleum-free fuels and chemicals. However, economies of scale currently make it challenging for these tiny creatures to compete with fossil fuels. Now, scientists at UC Davis are closer to meeting these challenges with a new advance that improves the production and growth rate of cyanobacteria.
UC Davis chemist Shota Atsumi is engineering these cyanobacteria to produce biofuels. (Photo by T.J. Ushing)
Visiting scholar Masahiro Kanno, graduate student Austin Carroll and chemistry professor Shota Atsumi introduced new genetic pathways into cyanobacteria that could help make microbe-based chemical production systems smaller and easier to operate.
By Holly Ober
Two UC Davis graduates have started a company incubated in the TEAM manufacturing facility at the UC Davis Department of Biomedical Engineering.
Arshia Firouzi and Gurkern Sufi met in 2011 as Freshmen living in Tercero Dormitories at UC Davis and quickly became friends. Arshia majored in Electrical Engineering and Gurkern in Biotechnology, and they worked with the mentorship of Professor Marc Facciotti to explore their shared interest in the intersection of electronics and biology. In 2015 they won a VentureWell grant for a research project, which they pursued in TEAM’s Molecular Prototyping and Bioinnovation Laboratory. By the end of their project, they had come up with an idea that grew into a company that could usher in a new era for laboratories all over the world.
UC Davis researchers have developed a way to use the empty shell of a Hepatitis E virus to carry vaccines or drugs into the body. The technique has been tested in rodents as a way to target breast cancer, and is available for commercial licensing through UC Davis Office of Research.
Hepatitis E virus is feco-orally transmitted, so it can survive passing through the digestive system, said Marie Stark, a graduate student working with Professor Holland Cheng in the UC Davis Department of Molecular and Cell Biology.
A new virus-killing peptide springs from an unexpected source: another virus, Hepatitis C.
Now biomedical engineers at UC Davis and Nanyang Technological University, Singapore show how the HCV alpha-helical (AH) peptide can make holes in the types of membranes that surround viruses. The work is published Jan. 5 in Biophysical Journal.
HCV-AH is known to be active against a wide range of viruses including West Nile, dengue, measles and HIV.
The HCV-AH peptide appears to target an Achilles’ heel common to many viruses, most likely a property of the lipid coating or envelope, said study author Atul Parikh, professor of biomedical engineering at UC Davis. That means that it’s less likely that viruses can readily evolve to become resistant to the peptide.
By Pat Bailey
As 2015 draws to a close, a team of UC Davis undergraduates can look back with pride and a sigh of relief on one of the most grueling but rewarding experiences of their college career.
Students Gabriel Freund, Muntaha Samad, Andrew Shepherd, Logan Vinson and Joanne Wu, were selected last spring as members of UC Davis’ 2015 iGEM (International Genetically Engineered Machines) team. They were joined by Andrew Michelmore, who is from Davis but attends Santa Clara University.
Gabriel Freund in the lab
By Kyeema Zerbe and Jennifer Hebets
The first ever event by the Innovation Institute for Food and Health (IIFH) struck surprising consensus in the food, agriculture and health agenda. The Challenge Definition Workshop held Oct. 29 set the stage for dialogue around such issues as crop selection, soil health, nutrition education, consumer decision-making, and technology feasibility – all under the overarching themes of health, sustainability, knowledge and governance. Next week, focus groups will deliberate the research questions behind such challenges, in preparation for the tour, hackathon and conference scheduled at the Solution Summit on December 2 and 3 in the UC Davis Conference Center.
By Kyeema Zerbe
The Innovation Institute for Food and Health (IIFH) at UC Davis is kicking off a uniquely open collaboration on solving critical challenges in food, agriculture and health with an open workshop Oct. 29 inviting participants from all disciplines to provide input on the institute’s strategic focus.
Food and nutrition insecurity remain serious issues for more than 50 developing countries, according to the 2015 Global Hunger Index. And even as many as 10 percent of populations in developed countries go hungry, including in the fertile lands of California’s Central Valley. The UN Food and Agriculture Organization reports that almost 800 million people worldwide are chronically undernourished. With the global population expected to reach nearly 10 billion by 2050, society faces an uncertain future that demands a coordinated response from all sectors to improve access to adequate nutrition.
By Jocelyn Anderson
Sponge-like nanoporous gold could be key to new devices to detect disease-causing agents in humans and plants, according to UC Davis researchers.
In two recent papers in Analytical Chemistry (here & here), a group from the UC Davis Department of Electrical and Computer Engineering demonstrated that they could detect nucleic acids using nanoporous gold, a novel sensor coating material, in mixtures of other biomolecules that would gum up most detectors. This method enables sensitive detection of DNA in complex biological samples, such as serum from whole blood.
When they think about how cells put together the molecules that make life work, biologists have tended to think of assembly lines: Add A to B, tack on C, and so on. But the reality might be more like a molecular version of a 3-D printer, where a single mechanism assembles the molecule in one go.
Take, for example, tubulin. Building from two subunits, alpha and beta tubulin, this protein assembles into microtubules that play a vital role inside cells – giving structure, pushing or pulling other things around, or providing a track on which other molecules can pull themselves along.
Despite decades of warnings about smoking, lung cancer is still the second-most common cancer and the leading cause of death from cancer in the U.S. Patients are often diagnosed only when their disease is already at an advanced stage and hard to treat. Researchers at the West Coast Metabolomics Center at UC Davis are trying to change that, by identifying biomarkers that could be the basis of early tests for lung cancer.
“Early diagnosis is the key to fighting lung cancer,” said Oliver Fiehn, director of the metabolomics center and a professor of molecular and cellular biology at UC Davis.